CABG shows survival benefits in study of patients with diabetes, CAD

08/13/2013 | Healio

Data on 232 patients with diabetes and multivessel coronary artery disease indicated that those who underwent coronary artery bypass graft surgery had lower rates of cardiac and overall mortality at 10 years, compared with those who received medical therapy. Differences in mortality rates between percutaneous coronary intervention and both medical therapy and CABG were not statistically significant, researchers reported in the American Heart Journal.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT